A Harvard addiction scientist and a former government lawyer are urging the
In a new paper published Wednesday in JAMA Psychiatry, the authors argue that the Biden administration’s push to reclassify cannabis relied on flawed reasoning and downplayed health risks, including cannabis-use disorder and links to psychosis.
Rescheduling would move cannabis into a lower-risk category, recognizing its potential medical use.
Photographer: Kyle Grillot/Bloomberg
The new paper adds to the arguments against rescheduling and could give the Trump administration more cover to block the move.
The
